| Brigatinib for ALK-positive metastatic non-small-cell lung cancer: design, development and place in therapy R Ali, J Arshad, S Palacio, R Mudad Drug design, development and therapy 13, 569, 2019 | 29 | 2019 |
| Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer S Palacio, A Loaiza-Bonilla, M Kittaneh, C Kyriakopoulos, RE Ochoa, ... Anticancer research 34 (1), 301-306, 2014 | 25 | 2014 |
| EGFR mutation testing: changing patterns of molecular testing in Brazil S Palacio, L Pontes, E Prado, J Arshad, R Ali, T Piha, CE Bacchi, ... The oncologist 24 (4), e137-e141, 2019 | 16 | 2019 |
| The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma S Palacio, PJ Hosein, I Reis, II Akunyili, V Ernani, T Pollack, J Macintyre, ... Journal of gastrointestinal oncology 9 (1), 135, 2018 | 15 | 2018 |
| A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan V Diaby, A Hussain, S van Boemmel-Wegmann, CY Wang, AA Ali, ... The Breast, 2019 | 13 | 2019 |
| What will we expect from novel therapies to esophageal and gastric malignancies? RA De Mello, L Castelo-Branco, P Castelo-Branco, DH Pozza, ... American Society of Clinical Oncology Educational Book 38, 249-261, 2018 | 4 | 2018 |
| P1. 06-018 EGFR Mutations and ALK Gene Rearrangements: Changing Patterns of Molecular Testing in Brazil S Palacio, G Lopes, R Mudad, E Prado Journal of Thoracic Oncology 12 (11), S1992, 2017 | 3 | 2017 |
| Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer. S Palacio, II Akunyili, V Ernani, J Macintyre, JR Merchan, T Pollack, I Reis, ... Journal of Clinical Oncology 33 (3_suppl), 413-413, 2015 | 3 | 2015 |
| Impact of timing of adjuvant chemotherapy initiation on survival in pancreatic adenocarcinoma. S Palacio, C Ripat, H Stuart, D Yakoub, NB Merchant Journal of Clinical Oncology 35 (4_suppl), 355-355, 2017 | 2 | 2017 |
| Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation S Palacio, T Pollack, R Silva-Smith, DA Sussman, PJ Hosein Journal of gastrointestinal oncology 9 (4), E19, 2018 | 1 | 2018 |
| A Case of Necrotizing Fasciitis from C. Septicum in A Neutropenic Patient Undergoing Chemotherapy for Angioimmunoblastic T-Cell Lymphoma V Patel, R Ali, S Palacio, J Byrnes, A Alencar Res Rev Clin Oncol Hematol: RRCOH-102. DOI 10, 2018 | 1* | 2018 |
| Prevalence of radiologic evidence of metastatic pancreatic ductal adenocarcinoma (PDAC) at first post-operative restaging studies in patients (pts) undergoing pancreatic cancer … S Palacio, PJ Hosein, JU Levi, JR Merchan, J Monge, L Portelance, ... Journal of Clinical Oncology 34 (4_suppl), 225-225, 2016 | 1 | 2016 |
| Deleterious alterations in DNA-damage repair (daDDR) genes as a predictive biomarker for platinum-based chemotherapy in metastatic pancreatic ductal adenocarcinoma (mPDAC). S Palacio, H Stowe McMurry, R Ali, T Donenberg, R Silva-Smith, ... Journal of Clinical Oncology 37 (4_suppl), 266-266, 2019 | | 2019 |
| Abstract P4-10-20: Breast cancer in Brazil: HER-2 testing and treatment patterns S Palacio, A Torres, E Prado, G Lopes Cancer Research 78 (4 Supplement), P4-10-20-P4-10-20, 2018 | | 2018 |
| Abstract P4-10-11: An active approach to genetic counseling in Trinidadian women with breast cancer SH George, GL Bravo, AC Sandoval, S Palacio, J Ali, TR Donenberg, ... Cancer Research 78 (4 Supplement), P4-10-11-P4-10-11, 2018 | | 2018 |
| Implementation of molecular testing for EGFR mutations and ALK rearrangement in lung adenocarcinoma in Brazil. S Palacio, G Lopes, E Prado Journal of Clinical Oncology 35 (15_suppl), e18002-e18002, 2017 | | 2017 |
| Influence of age on outcomes in pancreas adenocarcinoma (PAC): A single institution experience. G Tinoco, S Palacio, A Sandoval-Leon, D Kwon, T Pollack, II Akunyili, ... Journal of Clinical Oncology 34 (15_suppl), e15744-e15744, 2016 | | 2016 |
| Abstract P6-11-05: Chest imaging in patients with breast cancer treated with curative intent R Dawar, S Palacio, J Monge, A Torres, M Salzberg, LEM Castillo, ... Cancer Research 76 (4 Supplement), P6-11-05-P6-11-05, 2016 | | 2016 |
| Impact of Hispanic ethnicity on the clinical presentation and survival of esophageal and gastric cancer in south Florida. S Palacio, DA Sussman, B Ardalan, CMS Rocha Lima, PJ Hosein Journal of Clinical Oncology 32 (3_suppl), 125-125, 2014 | | 2014 |
